New insights into the molecular pathogenesis of intrahepatic cholangiocarcinoma

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Intrahepatic cholangiocarcinoma is an aggressive malignancy and is one of the most devastating cancers of the gastrointestinal tract. The molecular mechanisms contributing to the pathogenesis of these cancers are not well understood. The recognition and distinction of these cancers from other tumors such as perihilar or extrahepatic distal cholangiocarcinoma and hepatocellular carcinoma are important in defining the pathogenesis. New insights into molecular mechanisms contributing to disease pathogenesis are emerging from recent epidemiological, genome-wide profiling and laboratory based studies. These have contributed to an improved understanding of risk factors, genetic mutations and pathophysiological mechanisms that are associated with these tumors. The contribution of well-established risk factors such as biliary tract inflammation and key signaling pathways involved in intrahepatic cholangiocarcinoma are being further defined. These new insights have several important implications for both molecular diagnosis and therapy of these cancers.

Original languageEnglish (US)
Pages (from-to)165-172
Number of pages8
JournalJournal of Gastroenterology
Volume49
Issue number2
DOIs
StatePublished - Feb 2014

Fingerprint

Cholangiocarcinoma
Neoplasms
Gastrointestinal Neoplasms
Biliary Tract
Hepatocellular Carcinoma
Genome
Inflammation
Mutation

Keywords

  • Biliary tract cancers
  • Cholangiocytes
  • Liver cancers

ASJC Scopus subject areas

  • Gastroenterology

Cite this

New insights into the molecular pathogenesis of intrahepatic cholangiocarcinoma. / Patel, Tushar C.

In: Journal of Gastroenterology, Vol. 49, No. 2, 02.2014, p. 165-172.

Research output: Contribution to journalArticle

@article{7d69b7cd52e14737845d8a1dfe5aa4cf,
title = "New insights into the molecular pathogenesis of intrahepatic cholangiocarcinoma",
abstract = "Intrahepatic cholangiocarcinoma is an aggressive malignancy and is one of the most devastating cancers of the gastrointestinal tract. The molecular mechanisms contributing to the pathogenesis of these cancers are not well understood. The recognition and distinction of these cancers from other tumors such as perihilar or extrahepatic distal cholangiocarcinoma and hepatocellular carcinoma are important in defining the pathogenesis. New insights into molecular mechanisms contributing to disease pathogenesis are emerging from recent epidemiological, genome-wide profiling and laboratory based studies. These have contributed to an improved understanding of risk factors, genetic mutations and pathophysiological mechanisms that are associated with these tumors. The contribution of well-established risk factors such as biliary tract inflammation and key signaling pathways involved in intrahepatic cholangiocarcinoma are being further defined. These new insights have several important implications for both molecular diagnosis and therapy of these cancers.",
keywords = "Biliary tract cancers, Cholangiocytes, Liver cancers",
author = "Patel, {Tushar C}",
year = "2014",
month = "2",
doi = "10.1007/s00535-013-0894-y",
language = "English (US)",
volume = "49",
pages = "165--172",
journal = "Journal of Gastroenterology",
issn = "0944-1174",
publisher = "Springer Japan",
number = "2",

}

TY - JOUR

T1 - New insights into the molecular pathogenesis of intrahepatic cholangiocarcinoma

AU - Patel, Tushar C

PY - 2014/2

Y1 - 2014/2

N2 - Intrahepatic cholangiocarcinoma is an aggressive malignancy and is one of the most devastating cancers of the gastrointestinal tract. The molecular mechanisms contributing to the pathogenesis of these cancers are not well understood. The recognition and distinction of these cancers from other tumors such as perihilar or extrahepatic distal cholangiocarcinoma and hepatocellular carcinoma are important in defining the pathogenesis. New insights into molecular mechanisms contributing to disease pathogenesis are emerging from recent epidemiological, genome-wide profiling and laboratory based studies. These have contributed to an improved understanding of risk factors, genetic mutations and pathophysiological mechanisms that are associated with these tumors. The contribution of well-established risk factors such as biliary tract inflammation and key signaling pathways involved in intrahepatic cholangiocarcinoma are being further defined. These new insights have several important implications for both molecular diagnosis and therapy of these cancers.

AB - Intrahepatic cholangiocarcinoma is an aggressive malignancy and is one of the most devastating cancers of the gastrointestinal tract. The molecular mechanisms contributing to the pathogenesis of these cancers are not well understood. The recognition and distinction of these cancers from other tumors such as perihilar or extrahepatic distal cholangiocarcinoma and hepatocellular carcinoma are important in defining the pathogenesis. New insights into molecular mechanisms contributing to disease pathogenesis are emerging from recent epidemiological, genome-wide profiling and laboratory based studies. These have contributed to an improved understanding of risk factors, genetic mutations and pathophysiological mechanisms that are associated with these tumors. The contribution of well-established risk factors such as biliary tract inflammation and key signaling pathways involved in intrahepatic cholangiocarcinoma are being further defined. These new insights have several important implications for both molecular diagnosis and therapy of these cancers.

KW - Biliary tract cancers

KW - Cholangiocytes

KW - Liver cancers

UR - http://www.scopus.com/inward/record.url?scp=84896723581&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896723581&partnerID=8YFLogxK

U2 - 10.1007/s00535-013-0894-y

DO - 10.1007/s00535-013-0894-y

M3 - Article

C2 - 24145988

AN - SCOPUS:84896723581

VL - 49

SP - 165

EP - 172

JO - Journal of Gastroenterology

JF - Journal of Gastroenterology

SN - 0944-1174

IS - 2

ER -